Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Indoco Remedies has informed that it has enclosed a Press Release on 14th September 2020 titled ‘Indoco receives USFDA approval for Apixaban Tablets’.
The above information is a part of company’s filings submitted to BSE.